Guardant Health AMEA (GH AMEA) teamed up with Core Diagnostics to offer liquid biopsy in India by organizing an India Roadshow from 15^th to 21^st December in four major cities in India, namely Mumbai, Bangalore, Hyderabad and New Delhi. The roadshow included Continuing Medical Education sessions which attracted 30 participants in Bangalore and 20 participants in New Delhi. GH AMEA’s Chief Medical Officer, Dr Steve Olsen, shared about our company’s flagship product, the Guardant360^® assay, with 35 participants in Apollo Hospital and 25 participants in the All India Institute of Medical Science.

As part of this roadshow, GH AMEA ran a booth with one of our channel partners, Core Diagnostics, at the Lung Cancer Year End Review Conference. During this conference, Dr Olsen shared about the advantages of using comprehensive liquid biopsies like the Guardant360^® assay.